कंपनी का अवलोकन
Ridgetech, Inc. operates as a wholesale distributor specializing in pharmaceutical and various other healthcare products within the People's Republic of China, utilizing a diversified operational model. The enterprise functions through three distinct business segments: Retail Drugstores, Online Pharmacy, and Drug Wholesale, facilitating both offline and online distribution channels. This organization is classified within the Healthcare sector, specifically under the industry of Pharmaceutical Retailers, which defines its primary business environment and regulatory landscape. The company currently maintains a market capitalization of $364,495 and generates an annual revenue of $119.94M, supported by a workforce of 61 employees. These valuation and revenue figures indicate that Ridgetech, Inc. operates as a micro-cap entity with a relatively small market presence compared to larger pharmaceutical peers, reflecting its niche role in the Chinese healthcare distribution ecosystem.
वित्तीय स्वास्थ्य
The financial statements reveal a revenue of $119.94M for the trailing twelve months, yet the net income stands at -$2,006,486, while EBITDA is reported at -$866,302. The significant divergence between the positive revenue figure and the substantial negative net income highlights a cost structure where operating expenses, likely including cost of goods sold and administrative costs, far exceed the gross profits generated by the business. Despite the negative net income and negative EBITDA, the company reports a positive free cash flow of $6.04M, which suggests a degree of financial flexibility derived from efficient working capital management or capital expenditure discipline. The company holds $13.94M in cash assets against total debt obligations of $4.66M, resulting in a debt-to-equity ratio of 15.65. While the cash position exceeds total debt, the elevated debt-to-equity metric indicates a leveraged balance sheet structure relative to its equity base. The current ratio is recorded at 1.82, a figure that indicates the company possesses sufficient current assets to cover its short-term liabilities with a comfortable margin. However, the return on equity is negative at -8.0%, and the return on assets is negative at -1.2%, which reveals that management is currently generating negative returns on the capital invested by shareholders and the total asset base.
मूल्यांकन आकलन
Trailing P/E and forward P/E metrics are both listed as N/A due to the lack of positive earnings, which implies that traditional earnings-based valuation models are not applicable for assessing expected earnings trajectories at this time. The price-to-book ratio is stated at 0.59, indicating that the market values the company at approximately 41% below its net book value, suggesting no market premium over the underlying assets. Alternative valuation metrics provide further insight, with a price-to-sales ratio of 0.00 and an EV/EBITDA of 10.57, suggesting that the valuation is heavily discounted relative to sales and enterprise value metrics. The stock has exhibited extreme price volatility over the past year, with a 52-week high of $5.07 and a 52-week low of $0.02. Given the 52-week high of $5.07 and the current price implied by the market cap and share structure, the stock is trading at a level significantly below the recent 52-week high, reflecting the market's pricing of the company's current financial distress. The beta value is 0.18, which means the stock price exhibits very low volatility relative to the broader market, moving only one-eighth of the magnitude of the market index.
Growth & Income
The revenue growth year-over-year is negative at -11.7%, while earnings growth is N/A due to the company's recent losses. Since earnings are negative, it is impossible to determine if earnings are growing faster or slower than revenue in a traditional sense, but the contraction in revenue suggests a shrinking top line that impacts the ability to return to profitability. As a non-dividend payer, the company does not distribute a dividend yield or maintain a payout ratio, as both are listed as N/A and 0.0% respectively. This absence of dividend payments indicates that the company reinvests any available cash flow or retains earnings to fund operations and potentially pursue growth initiatives rather than providing income to shareholders. The overall growth and income profile for Ridgetech, Inc. is characterized by revenue contraction, a lack of current profitability, and an absence of dividend income, presenting a high-risk investment scenario focused on operational turnaround rather than capital appreciation through earnings or yield.